The price, and that is confidential & was negotiated for a total of 300 zillion doses, is slightly lower than the $19.50 a shot the United States agreed to buy a first shipment of hundred million doses of the identical vaccine, in line with what Reuters claimed in November.
The EU file dated Nov. 18 was circulated internally after the EU announced its supply offer with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is likely to determine on Monday on approval for the Pfizer vaccine after the photo was authorised in a few countries, including Britain and also the United States.
On Thursday Belgian state secretary for the budget Eva De Bleeker published on Twitter a dining room table with prices Belgium would shell out pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the article shortly after posting.
In that dinner table the Pfizer vaccine was suggested as costing Belgium twelve euros ($14.6) per dose, top many to believe this was the total price agreed by the EU.
Various other vaccines in the family table were additionally shown with rates lower compared to prices disclosed by EU solutions.
“There is always a complete fee and a price upon delivery,” an EU official involved in talks with vaccine creators told Reuters when directed to clarify the big difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament last week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Underneath EU prior purchase deals for COVID 19 vaccines, the bloc believes upfront payments with companies to secure doses before they’re approved. After approvals, EU governments can pay the remainder to get reserved doses.
The EU has not revealed the upfront payment agreed with Pfizer.
Nevertheless, it said in October that it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with an additional 1.45 billion euros budgeted for upfront payments to Pfizer BioNTech, Curevac and Moderna.
It has since agreed supply deals with all 6 businesses and is negotiating a seventh understanding with Novavax.